qtrly free cash flow was $136 million, or $4.7 billion at quarter end.
qtrly total company orders and revenue increased 48% and 25% respectively.
q2 adjusted ebitda $292 million versus refinitiv ibes estimate of $291.2 million.
board of directors approved new $20 million share repurchase authorization and announced new $15 million stock repurchase program.
qtrly organic orders increased 41% and revenue increased 17%.
qtrly corporate costs were $38 million, up year-over-year, primarily due to higher incentive compensation costs and targeted commercial growth investments.
qtrly book-to-bill of 1.14.
expect to add approximately $3.8 billion to pst addressable market, which is an impressive 40% expansion.
qtrly net debt to adjusted ebitda ratio of 0.2 times.
reaffirms its previously announced $300 million cost savings target.
qtrly organic orders increased 9% and 6% on a quarter-to-quarter and year-over-year basis.
compname reports q4 adjusted earnings per share of $0.40.
sees fy savings of $300 million to $350 million.
qtrly adjusted ebitda of $292 million, up 34% versus prior year.
qtrly average revenue grew 5% to $5.2 billion.
compname announces $85 per share share repurchase offer.
